milrinone has been researched along with Amyloidosis in 1 studies
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone is a phosphodiesterase type III inhibitor with positive inotropic and vasodilatory effects." | 5.31 | Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis. ( Ewald, G; Mindel, G; Saab, G; Vijayan, A, 2002) |
| "Milrinone is a phosphodiesterase type III inhibitor with positive inotropic and vasodilatory effects." | 1.31 | Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis. ( Ewald, G; Mindel, G; Saab, G; Vijayan, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saab, G | 1 |
| Mindel, G | 1 |
| Ewald, G | 1 |
| Vijayan, A | 1 |
1 other study available for milrinone and Amyloidosis
| Article | Year |
|---|---|
Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Amyloidosis; Cardiotonic Agents; Dobutamine; Drug Adm | 2002 |